Senator Murray Statement on Supreme Court Staying Unprecedented Attack on Medication Abortion and FDA's Ability to Do Its Job

Date: April 21, 2023
Location: Washington, D.C.
Issues: Abortion

"This stay offers a temporary sigh of relief after anti-abortion extremists determined to control women's bodies by any means possible have caused weeks of chaos and confusion. Mifepristone, a safe and effective medication approved by the FDA 23 years ago, for now remains on the shelves and available to women and patients.

"But this fight is not nearly over--and let's just be clear: it is absolutely outrageous this case ever made it this far. Again, mifepristone was approved by the FDA after careful review over twenty years ago--and has been safely used by more than 5 million women in the years since. Only now--after overturning Roe--have Republican extremists decided to file an unprecedented lawsuit that would not only deny women in every state access to this critical drug, but would threaten patients' access to all kinds of other drugs by upending and politicizing the FDA's expert-driven approvals process.

"Enough already. We've now got to win this case for good--to protect patients' access to a critical drug that's safer than Tylenol and to protect the FDA's trusted ability to simply do its job. My colleagues and I will be focused on doing just that, and I urge the administration to continue aggressively fighting this dangerous lawsuit."


Source
arrow_upward